GARD Steering committee report J Bousquet, R Dahl

1. GARD Steering committee report J Bousquet, R Dahl

2. Steering committee report 1- Consequences for GARD of the publication of the WHO Chronic Disease report 2- GARD members 3- Modified TOR 4- Preparation of the Launch 5- "GARD manual" 6- Dissemination of GARD to countries

3. Step 2 Step 1 Step 3 GARD Stepwise approach May 2005 GARD priorities Integrated GARD action plan Pilot studies in countries GARD action plan in countries 2005 2006 2007 2008 2009 2010

4. Step 2 Step 1 Step 3 GARD Stepwise approach March 2006 GARD priorities Integrated GARD action plan Pilot studies in countries GARD action plan in countries 2005 2006 2007 2008 2009 2010

5. Steering committee report 1- Consequences for GARD of the publication of the WHO Chronic Disease report

6. October 5, 2005

7. Estimate population needs and advocate WG.1- Burden, risk factors and surveillance (G Viegi, S Buist, Y Fukuchi) WG.2- Awareness and advocacy (C Lenfant, A Turnbull, P van Cauwenberge)

8. Formulate and adopt policy WG.3- Prevention and health promotion (M Boland, A Custovic) WG.4- Diagnosis of CRD (K Rabe, S Wenzel) WG.5- Control of CRD and allergies, Availability and affordability of drugs (J Bousquet, E Bateman, L Fabbri, C van Weel) WG.6- Pediatric asthma (C Baena-Cagnani, E Mantzouranis, FER Simons, E Valovirta)

9. Formulate and adopt policy WG.3- Prevention and health promotion (M Boland, A Custovic) WG.4- Diagnosis of CRD (K Rabe, S Wenzel) and allergy (GW Canonica) WG.5- Control of CRD and allergies, Availability and affordability of drugs (J Bousquet, E Bateman, L Fabbri, C van Weel) WG.6- Pediatric asthma (C Baena-Cagnani, E Mantzouranis, FER Simons, E Valovirta)

10. Formulate and adopt policy WG.3- Prevention and health promotion (M Boland, A Custovic) WG.4- Diagnosis of CRD (K Rabe, S Wenzel) and allergy (GW Canonica) WG.5- Control of CRD and allergies (J Bousquet, E Bateman, L Fabbri, C van Weel) Availability and affordability of drugs (N Aït Khaled) WG.6- Pediatric asthma (C Baena-Cagnani, E Mantzouranis, FER Simons, E Valovirta)

11. Current management of CRD • In high income countries • patients can receive adequate diagnosis and treatment • but they are insufficiently diagnosed and treated • a disease-specific approach is needed • the goals of GARD are to better diagnose, treat and educate • patients • In upper-middle income countries • few patients can receive adequate diagnosis and treatment • the first goals of GARD are to reduce under-diagnosis • the second goals of GARD are to provide accessible and • affordable treatment for all patients • a syndromic approach (PAL) is needed in many places • In lower-middle and low income countries • very few patients can receive adequate diagnosis and • treatment • the first goals of GARD are to reduce under-diagnosis • the second goals of GARD are to provide accessible • and affordable treatment for all patients • a syndromic approach (PAL) is needed in most places • In all countries, health promotion • and prevention are essential • control by disease-specific approach • control by syndromic approach • no control

12. GARD policy • In high income countries • patients can receive adequate diagnosis and treatment • but they are insufficiently diagnosed and treated • a disease-specific approach is needed • the goals of GARD are to better diagnose, treat and educate • patients • In upper-middle income countries • few patients can receive adequate diagnosis and treatment • the first goals of GARD are to reduce under-diagnosis • the second goals of GARD are to provide accessible and • affordable treatment for all patients • a syndromic approach (PAL) is needed in many places • In lower-middle and low income countries • very few patients can receive adequate diagnosis and • treatment • the first goals of GARD are to reduce under-diagnosis • the second goals of GARD are to provide accessible • and affordable treatment for all patients • a syndromic approach (PAL) is needed in most places • In all countries, health promotion • and prevention are essential • control by disease-specific approach • control by syndromic approach • no control

13. Identify Policy Implementation Steps • National Coordination: • The GARD action plan should be applied at the country level • Establishnational working groups with a national coordinator • The national coordination group will: • Provide existing national statistics on CRD and allergies • Assess the specific needs for the given country • Review the GARD action plan • Determine the relevant issues for the country action plan • Develop a country-specific action plan

14. Steering committee report 1- Consequences for GARD of the publication of the WHO Chronic Disease report 2- GARD members

15. WHO calls for a global and coordinated effort to fight chronic respiratory diseases WE ARE GARD!

16. GARD members Governments Pharmaceutical industry "Medical" Foundations Governmental organizations Scientific societies Patient's organizations Other NGOs Year 1 Year 2

17. Targetted approach GARD members Governments Pharmaceutical industry "Medical" Foundations Governmental organizations Scientific societies Patient's organizations Other NGOs Year 1 Year 2

18. Foundations Private sector GARD members World Bank Unesco and others Governments Pharmaceutical industry "Medical" Foundations Governmental organizations Scientific societies Patient's organizations Other NGOs Year 1 Year 2

19. Foundations Targetted approach first Global approach later Private sector GARD members World Bank Unesco and others Governments Pharmaceutical industry "Medical" Foundations Governmental organizations Scientific societies Patient's organizations Other NGOs Year 1 Year 2

20. Steering committee report 1- Consequences for GARD of the publication of the WHO Chronic Disease report 2- GARD members 3- Modified TOR

21. TOR december 2004: approved by members • Assembly meeting: revision of TOR NOT sent to WHO • to include private sector, WHO proposed a revised TOR (TOR2) (january 2006) • TOR2 should be discussed during the meeting and proposal sent to WHO GARD TOR

22. Steering committee report 1- Consequences for GARD of the publication of the WHO Chronic Disease report 2- GARD members 3- Modified TOR 4- Preparation of the Launch

23. "Hundreds of millions of people suffer from chronic respiratory diseases worldwide, including: • o 300 million people with asthma • o 62 million people with moderate to severe COPD • o Millions of others with mild COPD, allergic rhinitis, and other chronic respiratory diseases, which are often undiagnosed." Fact sheet

24. Chronic respiratory diseases TOTAL: Hundreds of millions

25. Chronic respiratory diseases TOTAL: > ONE BILLION

26. Steering committee report 1- Consequences for GARD of the publication of the WHO Chronic Disease report 2- GARD members 3- Modified TOR 4- Preparation of the Launch 5- "GARD manual"

27. GARD manual Geneva « pre-GARD » WHO meeting GARD Launch GARD meeting 1st GARD/WHO meeting GARD accepted by WHO 1st GARD assembly 09-05 28-03-06 06-04 09-04 01-05 05-05

28. Fact sheets Press release GARD manual GARD source document Geneva « pre-GARD » WHO meeting GARD Launch GARD meeting 1st GARD/WHO meeting GARD accepted by WHO 1st GARD assembly 09-05 28-03-06 06-04 09-04 01-05 05-05

29. Public Health guide Pocket guide Review Published by NGOs GARD manual GARD source document Geneva « pre-GARD » WHO meeting GARD Launch GARD meeting 1st GARD/WHO meeting Launch at ERS GARD accepted by WHO 1st GARD assembly 09-05 28-03-06 06-04 09-04 01-05 05-05

30. Steering committee report 1- Consequences for GARD of the publication of the WHO Chronic Disease report 2- GARD members 3- Modified TOR 4- Preparation of the Launch 5- "GARD manual" 6- Dissemination of GARD to countries

31. Activities within countries • China: launch, Chinese Medical Association • Brazil: Minister of Health (PAHO) • Poland: Minister of Health • India: President • Japan, Korea..: National coordination • Cape Verde, Russia, Tunisia: Pilot studies